Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients-A prospective study

Gynecologic Oncology

Volumn 104, Issue 3, 2007, Pages 721-726

  Lukaszuk, Krzysztof ^a   Liss, Joanna ^b   Gulczynski, Jacek ^c   Nowaczyk, Monika ^a   Nakonieczny, Miroslaw ^a   Piatkowski, Mariusz ^b   Sliwinski, Wojciech ^b   Baay, Marc ^d   Wozniak, Izabela ^a   Maj, Bozena ^b   Lukaszuk, Mariusz ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Prophylactic Centre   (Poland)

^c Maritime Hospital   (Poland)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cervical cancer; HPV; Lymph node; Metastasis

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; METASTASIS; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RADICAL HYSTERECTOMY; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; WART VIRUS;

DNA, VIRAL; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 33846899738     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.10.018     Document Type: Article

References (26)

1. Bosch F.X., Manos M.M., Munoz N., et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer. (IBSCC) Study Group. J. Natl. Cancer Inst. 87 (1995) 796-802
2. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynaecological system: an analysis of 1973-1987 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol. 10 (1994) 31-46
3. Kobayashi Y., Yoshinouchi M., Tiangi G., et al. Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer patients with histologically negative lymph nodes. Clin. Cancer Res. 4 (1998) 979-983
4. Sapy T., Hernandi Z., Konya Y., and Lukacsko L. Poor clinical outcome in early stage cervical cancer with human papillomavirus-18 positive lymph nodes. Eur. J. Obstet. Gynecol. Reprod. Biol. 90 (2000) 93-95
5. Hording U., Ravn V., Knudsen J., and Visfeld J. The use of polymerase chain reaction to detect metastatic cancer cells within lymph nodes in stage I cervical carcinoma. In J Gynecol Pathol 14 (1995) 339-343
6. Baay M.F., Koudstaal J., Hollema H., et al. Detection of HPV 16 DNA by PCR in histologically cancer free lymph nodes from patients with cervical cancer. J. Clin. Pathol. 50 (1997) 960-961
7. Czegledy J., Josif C., Forslund O., Willen R., and Hanson B.G. Detection of human papilloma virus DNA in lymph nodes extirpated at radical surgery for cervical cancer is not predictive of recurrence. J. Med. Virol. 54 (1998) 183-185
8. Pilch H., Gunzel S., Schaffer U., et al. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes-Correlation with clinico-pathological parameters and prognostic significance. Zentralbl. Gynacol. 123 (2001) 91-101
9. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet. Gynecol. 44 (1974) 265-272
10. Fujinaga Y., Shimada M., Okazawa K., Fukushima M., Kato I., and Fujinaga K. Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J. Gen. Virol. 72 (1991) 1039-1044
11. Kado S., Kawamata Y., Shino Y., et al. Detection of human papillomaviruses in cervical neoplasias using multiple sets of generic polymerase chain reaction primers. Gynaecol. Oncol. 81 (2001) 47-52
12. Kamura T., Tsukamoto N., Tsuruchi N., Saito T., Matsuyama T., and Akazawa M.S. Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy. Cancer 71 (1993) 1422-1437
13. Chen C.A., Chen T.M., Wu C.C., Huang C.F., and Hsieh C.Y. The genotypes and prognostic significance of human papillomaviruses in cervical cancer. Int. J. Cancer 57 (1994) 181-184
14. Zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49 (1990) 4677-4681
15. Eluf Neto J., Booth M., Munoz M., Bosh F.X., Meijer C.J., and Walboomers J.M. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer 69 (1994) 114-119
16. Van Bommel P., van den Brule A., Helmerhorst T., et al. HPV DNA presence and HPV genotypes as prognostic factors in low stage squamous cell cervical cancer. Gynecol. Oncol. 48 (1993) 333-337
17. Lukaszuk K., Wozniak I., Emerich J., and Wojcikowski C. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J. Clin. Microbiol. 41 (2003) 608-612
18. Lukaszuk K., Liss J., Wozniak I., Sliwinski W., Emerich J., and Wojcikowski C. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study. J. Clin. Pathol. 57 (2004) 472-476
19. Fule T., Csapo Z., Mathe M., et al. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol. Oncol. 100 (2006) 570-578
20. Kamura T., Shigematsu T., Kaku T., et al. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy. Acta Obstet. Gynecol. Scand. 78 (1999) 452-457
21. Kristensen G.B., Abeler V.M., Risberg B., Trop C., and Bryne M. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol. Oncol. 74 (1999) 245-251
22. Lai C.H., Hong J.H., Hsueh S., et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 85 (1999) 1537-1546
23. Aoki Y., Sasaki M., Watanabe M., et al. High-risk group in node-positive patients with stage IB,IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol. Oncol. 77 (2000) 305-309
24. Garipagaoglu M., Tulunay G., Kose M.F., Yalvac S., Kayikcioglu F., and Cakmak A. Prognostic factors in stage IB-IIA cervical carcinomas treated with postoperative radiotherapy. Eur. J. Gynaecol. Oncol. 20 (1999) 131-135
25. Im S.S., Wilczynski S.P., Burger R.A., and Monk B.J. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion. Clin. Cancer Res. 9 (2003) 4145-4150
26. Pilch H., Gunzel S., Schaffer U., et al. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int. J. Gynecol. Cancer 11 1 (2001 (Jan-Feb)) 39-48